Cargando…

Pay attention to situation of SARS-CoV-2 and TCM advantages in treatment of novel coronavirus infection

Since the outbreak of the new coronavirus epidemic, novel coronavirus has infected nearly 100,000 people in more than 110 countries. How to face this new coronavirus epidemic outbreak is an important issue. Basic reproduction number (R0) is an important parameter in epidemiology; The basic reproduct...

Descripción completa

Detalles Bibliográficos
Autor principal:	Liu, Chang-xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270776/ https://www.ncbi.nlm.nih.gov/pubmed/32518555 http://dx.doi.org/10.1016/j.chmed.2020.03.004

Ejemplares similares

Pay attention to SARS‐CoV‐2 infection in children
por: Xie, Zhengde
Publicado: (2020)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Diversity of Coronaviruses with Particular Attention to the Interspecies Transmission of SARS-CoV-2
por: Shehata, Awad A., et al.
Publicado: (2022)

SARS-Coronavirus (SARS-CoV)
por: Kehm, Roland
Publicado: (2009)

SARS-CoV-2 Infected Cases with Untraceable Epidemic Origin: Its Values, Identification and TCM Treatment in Preventing Recurrence()
por: Kai, Li, et al.
Publicado: (2020)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

The advantages of drug treatment with statins in patients with SARS-CoV-2 infection
por: Ferrara, Francesco, et al.
Publicado: (2021)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

Attention Pays
por: James, Neen
Publicado: (2018)

Could nanotechnology assist traditional Chinese medicine (TCM) in photodynamic therapy (PDT) against SARS-CoV-2?
por: Law, Siukan, et al.
Publicado: (2021)

Chloroquine for the 2019 novel coronavirus SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020)

Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques
por: Shan, Chao, et al.
Publicado: (2020)

Paying attention to attention in depression
por: Keller, Arielle S., et al.
Publicado: (2019)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
por: Dong, Yetian, et al.
Publicado: (2020)

Novel Inhibitors of 2′-O-Methyltransferase of the SARS-CoV-2 Coronavirus
por: Sulimov, Alexey, et al.
Publicado: (2022)

SARS-CoV-2 Variants in Lebanon: Evolution and Current Situation
por: Fayad, Nancy, et al.
Publicado: (2021)

Vaccins Sars-CoV-2 : pays riches, laissez-en aux autres !
por: Dalmat, Yann-Mickael
Publicado: (2021)

Coronavirus (SARS-CoV-2) in gastroenterology and its current epidemiological situation: An updated review until January 2021
por: Nabil, Ahmed, et al.
Publicado: (2021)

The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2
por: Zhu, James, et al.
Publicado: (2020)

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
por: Tung, Tao-Hsin, et al.
Publicado: (2022)

Focus on a 2019-novel coronavirus (SARS-CoV-2)
por: Zhang, Ling-Pu, et al.
Publicado: (2020)

Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
por: Younes, Nadin, et al.
Publicado: (2020)

Promising methods for detection of novel coronavirus SARS‐CoV‐2
por: Liu, Ran, et al.
Publicado: (2020)

Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2
por: Rehman, Saif ur, et al.
Publicado: (2020)

Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)
por: Kumar, Swatantra, et al.
Publicado: (2020)

Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages
por: Pérez-López, Briza, et al.
Publicado: (2021)

Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron
por: van Dorp, Christiaan, et al.
Publicado: (2022)

Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron
por: van Dorp, Christiaan, et al.
Publicado: (2022)

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
por: Echaide, Miriam, et al.
Publicado: (2023)

Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19)
por: Al-Tawfiq, Jaffar A.
Publicado: (2020)

Learning to Pay Attention
por: Jones, Rachel
Publicado: (2007)

Paying Attention to Memory
Publicado: (2004)

A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV
por: Singh, Ashutosh, et al.
Publicado: (2020)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
por: Sessa, Francesco, et al.
Publicado: (2021)

An Exploration of Nanoparticle-Based Diagnostic Approaches for Coronaviruses: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Al-Hindawi, Ahmed, et al.
Publicado: (2022)

Biology of the SARS-CoV-2 Coronavirus
por: Mingaleeva, Rimma N., et al.
Publicado: (2023)

The novel coronavirus (SARS-CoV-2) infections in China: prevention, control and challenges
por: Zhang, Sheng, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection
por: Bhuiyan, Taufiqur Rahman, et al.
Publicado: (2022)

Correction: Paying attention to attention in depression
por: Keller, Arielle S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9g064oshqskg26uppq3394lm57